GLP-1 drugs carry real safety risks that the FDA formalized in updated labeling in 2025, and the long-term effects of taking these medications for longevity purposes in otherwise healthy people remain entirely unknown
baseline) (STEP 1 trial extension)
R., Hartoft-Nielsen, M., et al
Since any weight-loss benefits are only realized while youre taking the drug, patients seemingly have to take it indefinitely and its unclear what the long-term use of semaglutide may look like
This creates a two-track experience: patients seeking brand-name Wegovy, Ozempic, Mounjaro, or Zepbound through Nurx get the prescription and clinical oversight from Nurx, but handle medication procurement and cost directly through their own pharmacy and insurance